These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25007361)

  • 21. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
    Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
    Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
    Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
    J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
    Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
    Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized double-blind trial of tromantadine versus aciclovir in recurrent herpes orofacialis.
    Ostheimer KE; Busch T; Görtelmeyer R; Hahn KD
    Arzneimittelforschung; 1989 Sep; 39(9):1152-5. PubMed ID: 2686658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
    J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.
    Tyring S; Wald A; Zadeikis N; Dhadda S; Takenouchi K; Rorig R
    J Infect Dis; 2012 Apr; 205(7):1100-10. PubMed ID: 22351940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tromantadine and aciclovir in the topical treatment of recurrent herpes orofacialis. Comparison in a clinical trial.
    Diezel W; Michel G; Görtelmeyer R; Ostheimer KE
    Arzneimittelforschung; 1993 Apr; 43(4):491-6. PubMed ID: 8494582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.
    Gilbert SC
    J Drugs Dermatol; 2007 Apr; 6(4):400-5. PubMed ID: 17668537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes Labialis: An Update.
    Leung AKC; Barankin B
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
    Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA; Trottier S; Miller JM
    Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.